Roche FY2026 Earnings Forecast Increased by Erste Group Bank

Roche Holding AG (OTCMKTS:RHHBY – Free Report) – Equities research analysts at Erste Group Bank upped their FY2026 earnings per share estimates for Roche in a research note issued on Wednesday, October 21st. Erste Group Bank analyst H. Engel now anticipates that the company will post earnings per share of $3.10 for the year, up from their previous forecast of $3.05. The consensus estimate for Roche’s current full-year earnings is $3.02 per share. Erste Group Bank also issued estimates for Roche’s FY2027 earnings at $3.36 EPS.

Several other research firms have also weighed in on RHHBY. Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a report on Monday, August 24th. HSBC reiterated a “hold” rating on shares of Roche in a report on Thursday, September 10th. Royal Bank Of Canada initiated coverage on shares of Roche in a report on Tuesday, September 8th. They set an “outperform” rating for the company. Oddo Bhf upgraded shares of Roche to an “outperform” rating in a report on Tuesday, October 20th. Finally, Morgan Stanley raised Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective for the company in a research report on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $60.00.

Read Our Latest Stock Report on RHHBY

Roche Trading Up 0.7%

RHHBY opened at $60.37 on Wednesday. The stock has a 50-day moving average of $55.39 and a 200-day moving average of $53.62. Roche has a 52-week low of $40.07 and a 52-week high of $61.49.

Institutional Investors Weigh In On Roche

A number of institutional investors have recently bought and sold shares of the business. McIlrath & Eck LLC bought a new stake in Roche in the 1st quarter valued at $39,000. Renasant Bank bought a new position in shares of Roche during the 2nd quarter worth about $210,000. Pinnacle Wealth Management Advisory Group LLC acquired a new stake in shares of Roche during the 1st quarter valued at about $208,000. Woodstock Corp acquired a new stake in shares of Roche during the 3rd quarter valued at about $245,000. Finally, Enterprise Financial Services Corp increased its stake in Roche by 6.6% in the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after acquiring an additional 345 shares during the period.

Roche Company Profile

(Get Free Report)

Roche Holding AG is a Switzerland-based healthcare company focused on pharmaceuticals and diagnostics. Founded in 1896 and headquartered in Basel, Roche develops medicines and diagnostic technologies intended to support the prevention, diagnosis and treatment of serious diseases.

The company’s pharmaceutical business concentrates on areas including oncology, immunology, neuroscience, ophthalmology and hematology. Its products include targeted cancer therapies, treatments for multiple sclerosis and hemophilia, and medicines for other specialized conditions.

See Also

Earnings History and Estimates for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.